Showing results (211-220 of 1,036) with videos related to
Sort By:
Pageof 104
Biochemical Pharmacology|October 15, 1986
Hypophysectomy may non-selectively alter pharmacokinetic parameters to enhance the ability of haloperidol to increase striatal dopamine receptor density in the ratM D Simpson, P Jenner, C D MarsdenBritish Journal of Clinical Pharmacology|January 1, 1977
Nomifensine in Parkinson's diseaseP Bedard, J D Parkes, C D MarsdenThe Journal of Pharmacy and Pharmacology|May 1, 1985
Properties of rat striatal D-2 dopamine receptors solubilized with the zwitterionic detergent CHAPSG J Kilpatrick, P Jenner, C D MarsdenBrain : a Journal of Neurology|April 1, 1992
Simple and choice reaction time and the use of advance information for motor preparation in Parkinson's diseaseM Jahanshahi, R G Brown, C D MarsdenNeurology|December 1, 1992
New insights into the cause of Parkinson's diseaseP Jenner, A H Schapira, C D MarsdenJournal of Neurology, Neurosurgery, and Psychiatry|April 1, 1975
Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesiasD Tarsy, J D Parkes, C D MarsdenArchives of Neurology|February 1, 1975
Clonidine in Parkinson diseaseD Tarsy, J D Parkes, C D MarsdenNeurology|February 1, 1991
Dopa-responsive dystonia: long-term treatment response and prognosisT G Nygaard, C D Marsden, S FahnBiochemical Pharmacology|July 25, 1991
A redox reaction between MPP+ and MPDP+ to produce superoxide radicals does not impair mitochondrial functionM J Walker, P Jenner, C D MarsdenBrain : a Journal of Neurology|August 1, 1993
Response choice in Parkinson's disease. The effects of uncertainty and stimulus-response compatibilityR G Brown, M Jahanshahi, C D MarsdenPageof 104